J

Researcher Profile

JeeHye Suh

🏛 Celltrion, Inc., Incheon, Republic of Korea

2

Publications

21

Citations

10

Co-Authors

1

Active Years

Publications

Open Access Journal Article Expert Opinion on Biological Therapy Feb 22, 2024

A randomized, double-blind, single-dose, phase 1 study comparing the pharmacokinetics, pharmacodynamics, safety, and immunogenicity of denosumab biosimilar CT‑P41 and reference denosumab in healthy males

Anhye Kim · Jang Hee Hong · Wonsuk Shin · Hyounggyoon Yoo +8 more

10.1080/14712598.2024.2316846 7 citations

Open Access Journal Article Osteoporosis International Jul 23, 2024

Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis

Jean-Yves Reginster · Edward Czerwinski · Krzysztof Wilk · Przemysław Borowy +14 more

10.1007/s00198-024-07161-x 14 citations

Publication Timeline

2024

2

Frequent Co-Authors

Jean-Yves Reginster

Anna Strzelecka

Stuart Silverman

Przemysław Borowy